Literature DB >> 24548619

A unique C-terminal domain allows retention of matrix metalloproteinase-27 in the endoplasmic reticulum.

Antoine Cominelli1, Mathias Halbout, Francisca N'Kuli, Pascale Lemoine, Pierre J Courtoy, Etienne Marbaix, Donatienne Tyteca, Patrick Henriet.   

Abstract

Matrix metalloproteinase-27 (MMP-27) is poorly characterized. Sequence comparison suggests that a C-terminal extension (CTE) includes a potential transmembrane domain as in some membrane-type (MT)-MMPs. Having noticed that MMP-27 was barely secreted, we investigated its subcellular localization and addressed CTE contribution for MMP-27 retention. Intracellular MMP-27 was sensitive to endoglycosidase H. Subcellular fractionation and confocal microscopy evidenced retention of endogenous MMP-27 or recombinant rMMP-27 in the endoplasmic reticulum (ER) with locked exit across the intermediate compartment (ERGIC). Conversely, truncated rMMP-27 without CTE accessed downstream secretory compartments (ERGIC and Golgi) and was constitutively secreted. CTE addition to rMMP-10 (a secreted MMP) caused ER retention and blocked secretion. Addition of a PKA target sequence to the cytosolic C-terminus of transmembrane MT1-MMP/MMP-14 led to effective phosphorylation upon forskolin stimulation, but not for MMP-27, excluding transmembrane anchorage. Moreover, MMP-27 was protected from digestion by proteinase K. Finally, MT1-MMP/MMP-14 but neither endogenous nor recombinant MMP-27 partitioned in the detergent phase after Triton X-114 extraction, indicating that MMP-27 is not an integral membrane protein. In conclusion, MMP-27 is efficiently retained within the ER due to its unique CTE, which does not lead to stable membrane insertion. This could represent a novel ER retention system.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ERGIC; Triton X-114; brefeldin A; intermediate compartment; intracellular MMP; membrane; proteinase K; surface biotinylation

Mesh:

Substances:

Year:  2014        PMID: 24548619     DOI: 10.1111/tra.12149

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  6 in total

1.  The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.

Authors:  Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

Review 2.  Biochemical and Biological Attributes of Matrix Metalloproteinases.

Authors:  Ning Cui; Min Hu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-22       Impact factor: 3.622

3.  Loss of MMP-27 Predicts Mandibular Bone Invasion in Oral Squamous Cell Carcinoma.

Authors:  Jonas Eichberger; Florian Weber; Gerrit Spanier; Michael Gerken; Stephan Schreml; Daniela Schulz; Mathias Fiedler; Nils Ludwig; Richard Josef Bauer; Torsten Eugen Reichert; Tobias Ettl
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

4.  Dermal Fibroblast CCN1 Expression in Mice Recapitulates Human Skin Dermal Aging.

Authors:  Taihao Quan; Yaping Xiang; Yingchun Liu; Zhaoping Qin; Yan Yang; George Bou-Gharios; John J Voorhees; Andrzej A Dlugosz; Gary J Fisher
Journal:  J Invest Dermatol       Date:  2020-08-13       Impact factor: 8.551

Review 5.  Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.

Authors:  Salvatore Napoli; Chiara Scuderi; Giuseppe Gattuso; Virginia Di Bella; Saverio Candido; Maria Sofia Basile; Massimo Libra; Luca Falzone
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

Review 6.  The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.

Authors:  Cristian Scheau; Ioana Anca Badarau; Raluca Costache; Constantin Caruntu; Gratiela Livia Mihai; Andreea Cristiana Didilescu; Carolina Constantin; Monica Neagu
Journal:  Anal Cell Pathol (Amst)       Date:  2019-11-26       Impact factor: 2.916

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.